COVID-19 Impact on Global Isocitrate Dehydrogenase Inhibitors Market Size, Status and Forecast 2020-2026

August 2020 | 97 pages | ID: C545D5129DE6EN
QYResearch

Abstracts

This report focuses on the global Isocitrate Dehydrogenase Inhibitors status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Isocitrate Dehydrogenase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• AGIOS
• Aslan Pharmaceuticals
• Bayer
• Beigene
• Bristol-Myers Squibb
• Celgene
• Daiichi Sankyo
• Philogen S.p.A.
• Tesaro
• Tragara/Adastra
• Tocagen

Market segment by Type, the product can be split into

• IDH1 Mutant Medullary Malignant Tumor
• IDH2 Mutant Medullary Malignant Tumor
• Others

Market segment by Application, split into

• DH Inhibitor
• FLT3 Inhibitor
• Hedgehog Pathway Inhibitor
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Isocitrate Dehydrogenase Inhibitors status, future forecast, growth opportunity, key market and key players.
• To present the Isocitrate Dehydrogenase Inhibitors development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Isocitrate Dehydrogenase Inhibitors are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Isocitrate Dehydrogenase Inhibitors Revenue
1.4 Market Analysis by Type
  1.4.1 Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 IDH1 Mutant Medullary Malignant Tumor
  1.4.3 IDH2 Mutant Medullary Malignant Tumor
  1.4.4 Others
1.5 Market by Application
  1.5.1 Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2020 VS 2026
  1.5.2 DH Inhibitor
  1.5.3 FLT3 Inhibitor
  1.5.4 Hedgehog Pathway Inhibitor
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): Isocitrate Dehydrogenase Inhibitors Industry Impact
  1.6.1 How the Covid-19 is Affecting the Isocitrate Dehydrogenase Inhibitors Industry
    1.6.1.1 Isocitrate Dehydrogenase Inhibitors Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and Isocitrate Dehydrogenase Inhibitors Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for Isocitrate Dehydrogenase Inhibitors Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Isocitrate Dehydrogenase Inhibitors Market Perspective (2015-2026)
2.2 Isocitrate Dehydrogenase Inhibitors Growth Trends by Regions
  2.2.1 Isocitrate Dehydrogenase Inhibitors Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Isocitrate Dehydrogenase Inhibitors Historic Market Share by Regions (2015-2020)
  2.2.3 Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Isocitrate Dehydrogenase Inhibitors Market Growth Strategy
  2.3.6 Primary Interviews with Key Isocitrate Dehydrogenase Inhibitors Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Market Size
  3.1.1 Global Top Isocitrate Dehydrogenase Inhibitors Players by Revenue (2015-2020)
  3.1.2 Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Players (2015-2020)
  3.1.3 Global Isocitrate Dehydrogenase Inhibitors Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio
  3.2.1 Global Isocitrate Dehydrogenase Inhibitors Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Isocitrate Dehydrogenase Inhibitors Revenue in 2019
3.3 Isocitrate Dehydrogenase Inhibitors Key Players Head office and Area Served
3.4 Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
3.5 Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Isocitrate Dehydrogenase Inhibitors Historic Market Size by Type (2015-2020)
4.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Type (2021-2026)

5 ISOCITRATE DEHYDROGENASE INHIBITORS BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)
5.2 Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
6.2 Isocitrate Dehydrogenase Inhibitors Key Players in North America (2019-2020)
6.3 North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
6.4 North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
7.2 Isocitrate Dehydrogenase Inhibitors Key Players in Europe (2019-2020)
7.3 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
7.4 Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

8 CHINA

8.1 China Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
8.2 Isocitrate Dehydrogenase Inhibitors Key Players in China (2019-2020)
8.3 China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
8.4 China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
9.2 Isocitrate Dehydrogenase Inhibitors Key Players in Japan (2019-2020)
9.3 Japan Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
9.4 Japan Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
10.2 Isocitrate Dehydrogenase Inhibitors Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
10.4 Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

11 INDIA

11.1 India Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
11.2 Isocitrate Dehydrogenase Inhibitors Key Players in India (2019-2020)
11.3 India Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
11.4 India Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size (2015-2020)
12.2 Isocitrate Dehydrogenase Inhibitors Key Players in Central & South America (2019-2020)
12.3 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020)
12.4 Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 AGIOS
  13.1.1 AGIOS Company Details
  13.1.2 AGIOS Business Overview and Its Total Revenue
  13.1.3 AGIOS Isocitrate Dehydrogenase Inhibitors Introduction
  13.1.4 AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020))
  13.1.5 AGIOS Recent Development
13.2 Aslan Pharmaceuticals
  13.2.1 Aslan Pharmaceuticals Company Details
  13.2.2 Aslan Pharmaceuticals Business Overview and Its Total Revenue
  13.2.3 Aslan Pharmaceuticals Isocitrate Dehydrogenase Inhibitors Introduction
  13.2.4 Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.2.5 Aslan Pharmaceuticals Recent Development
13.3 Bayer
  13.3.1 Bayer Company Details
  13.3.2 Bayer Business Overview and Its Total Revenue
  13.3.3 Bayer Isocitrate Dehydrogenase Inhibitors Introduction
  13.3.4 Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.3.5 Bayer Recent Development
13.4 Beigene
  13.4.1 Beigene Company Details
  13.4.2 Beigene Business Overview and Its Total Revenue
  13.4.3 Beigene Isocitrate Dehydrogenase Inhibitors Introduction
  13.4.4 Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.4.5 Beigene Recent Development
13.5 Bristol-Myers Squibb
  13.5.1 Bristol-Myers Squibb Company Details
  13.5.2 Bristol-Myers Squibb Business Overview and Its Total Revenue
  13.5.3 Bristol-Myers Squibb Isocitrate Dehydrogenase Inhibitors Introduction
  13.5.4 Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.5.5 Bristol-Myers Squibb Recent Development
13.6 Celgene
  13.6.1 Celgene Company Details
  13.6.2 Celgene Business Overview and Its Total Revenue
  13.6.3 Celgene Isocitrate Dehydrogenase Inhibitors Introduction
  13.6.4 Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.6.5 Celgene Recent Development
13.7 Daiichi Sankyo
  13.7.1 Daiichi Sankyo Company Details
  13.7.2 Daiichi Sankyo Business Overview and Its Total Revenue
  13.7.3 Daiichi Sankyo Isocitrate Dehydrogenase Inhibitors Introduction
  13.7.4 Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.7.5 Daiichi Sankyo Recent Development
13.8 Philogen S.p.A.
  13.8.1 Philogen S.p.A. Company Details
  13.8.2 Philogen S.p.A. Business Overview and Its Total Revenue
  13.8.3 Philogen S.p.A. Isocitrate Dehydrogenase Inhibitors Introduction
  13.8.4 Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.8.5 Philogen S.p.A. Recent Development
13.9 Tesaro
  13.9.1 Tesaro Company Details
  13.9.2 Tesaro Business Overview and Its Total Revenue
  13.9.3 Tesaro Isocitrate Dehydrogenase Inhibitors Introduction
  13.9.4 Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.9.5 Tesaro Recent Development
13.10 Tragara/Adastra
  13.10.1 Tragara/Adastra Company Details
  13.10.2 Tragara/Adastra Business Overview and Its Total Revenue
  13.10.3 Tragara/Adastra Isocitrate Dehydrogenase Inhibitors Introduction
  13.10.4 Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  13.10.5 Tragara/Adastra Recent Development
13.11 Tocagen
  10.11.1 Tocagen Company Details
  10.11.2 Tocagen Business Overview and Its Total Revenue
  10.11.3 Tocagen Isocitrate Dehydrogenase Inhibitors Introduction
  10.11.4 Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
  10.11.5 Tocagen Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Isocitrate Dehydrogenase Inhibitors Key Market Segments
Table 2. Key Players Covered: Ranking by Isocitrate Dehydrogenase Inhibitors Revenue
Table 3. Ranking of Global Top Isocitrate Dehydrogenase Inhibitors Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of IDH1 Mutant Medullary Malignant Tumor
Table 6. Key Players of IDH2 Mutant Medullary Malignant Tumor
Table 7. Key Players of Others
Table 8. COVID-19 Impact Global Market: (Four Isocitrate Dehydrogenase Inhibitors Market Size Forecast Scenarios)
Table 9. Opportunities and Trends for Isocitrate Dehydrogenase Inhibitors Players in the COVID-19 Landscape
Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 11. Key Regions/Countries Measures against Covid-19 Impact
Table 12. Proposal for Isocitrate Dehydrogenase Inhibitors Players to Combat Covid-19 Impact
Table 13. Global Isocitrate Dehydrogenase Inhibitors Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 14. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (US$ Million): 2020 VS 2026
Table 15. Global Isocitrate Dehydrogenase Inhibitors Market Size by Regions (2015-2020) (US$ Million)
Table 16. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2015-2020)
Table 17. Global Isocitrate Dehydrogenase Inhibitors Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 18. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2021-2026)
Table 19. Market Top Trends
Table 20. Key Drivers: Impact Analysis
Table 21. Key Challenges
Table 22. Isocitrate Dehydrogenase Inhibitors Market Growth Strategy
Table 23. Main Points Interviewed from Key Isocitrate Dehydrogenase Inhibitors Players
Table 24. Global Isocitrate Dehydrogenase Inhibitors Revenue by Players (2015-2020) (Million US$)
Table 25. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players (2015-2020)
Table 26. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2019)
Table 27. Global Isocitrate Dehydrogenase Inhibitors by Players Market Concentration Ratio (CR5 and HHI)
Table 28. Key Players Headquarters and Area Served
Table 29. Key Players Isocitrate Dehydrogenase Inhibitors Product Solution and Service
Table 30. Date of Enter into Isocitrate Dehydrogenase Inhibitors Market
Table 31. Mergers & Acquisitions, Expansion Plans
Table 32. Global Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 33. Global Isocitrate Dehydrogenase Inhibitors Market Size Share by Type (2015-2020)
Table 34. Global Isocitrate Dehydrogenase Inhibitors Revenue Market Share by Type (2021-2026)
Table 35. Global Isocitrate Dehydrogenase Inhibitors Market Size Share by Application (2015-2020)
Table 36. Global Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 37. Global Isocitrate Dehydrogenase Inhibitors Market Size Share by Application (2021-2026)
Table 38. North America Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 39. North America Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 40. North America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 41. North America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 42. North America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 43. North America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 44. Europe Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 45. Europe Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 46. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 47. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 48. Europe Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 49. Europe Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 50. China Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 51. China Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 52. China Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 53. China Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 54. China Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 55. China Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 56. Japan Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 57. Japan Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 58. Japan Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 59. Japan Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 60. Japan Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 61. Japan Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 62. Southeast Asia Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 63. Southeast Asia Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 64. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 65. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 66. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 67. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 68. India Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 69. India Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 70. India Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 71. India Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 72. India Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 73. India Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 74. Central & South America Key Players Isocitrate Dehydrogenase Inhibitors Revenue (2019-2020) (Million US$)
Table 75. Central & South America Key Players Isocitrate Dehydrogenase Inhibitors Market Share (2019-2020)
Table 76. Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Type (2015-2020) (Million US$)
Table 77. Central & South America Isocitrate Dehydrogenase Inhibitors Market Share by Type (2015-2020)
Table 78. Central & South America Isocitrate Dehydrogenase Inhibitors Market Size by Application (2015-2020) (Million US$)
Table 79. Central & South America Isocitrate Dehydrogenase Inhibitors Market Share by Application (2015-2020)
Table 80. AGIOS Company Details
Table 81. AGIOS Business Overview
Table 82. AGIOS Product
Table 83. AGIOS Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 84. AGIOS Recent Development
Table 85. Aslan Pharmaceuticals Company Details
Table 86. Aslan Pharmaceuticals Business Overview
Table 87. Aslan Pharmaceuticals Product
Table 88. Aslan Pharmaceuticals Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 89. Aslan Pharmaceuticals Recent Development
Table 90. Bayer Company Details
Table 91. Bayer Business Overview
Table 92. Bayer Product
Table 93. Bayer Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 94. Bayer Recent Development
Table 95. Beigene Company Details
Table 96. Beigene Business Overview
Table 97. Beigene Product
Table 98. Beigene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 99. Beigene Recent Development
Table 100. Bristol-Myers Squibb Company Details
Table 101. Bristol-Myers Squibb Business Overview
Table 102. Bristol-Myers Squibb Product
Table 103. Bristol-Myers Squibb Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 104. Bristol-Myers Squibb Recent Development
Table 105. Celgene Company Details
Table 106. Celgene Business Overview
Table 107. Celgene Product
Table 108. Celgene Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 109. Celgene Recent Development
Table 110. Daiichi Sankyo Company Details
Table 111. Daiichi Sankyo Business Overview
Table 112. Daiichi Sankyo Product
Table 113. Daiichi Sankyo Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 114. Daiichi Sankyo Recent Development
Table 115. Philogen S.p.A. Business Overview
Table 116. Philogen S.p.A. Product
Table 117. Philogen S.p.A. Company Details
Table 118. Philogen S.p.A. Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 119. Philogen S.p.A. Recent Development
Table 120. Tesaro Company Details
Table 121. Tesaro Business Overview
Table 122. Tesaro Product
Table 123. Tesaro Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 124. Tesaro Recent Development
Table 125. Tragara/Adastra Company Details
Table 126. Tragara/Adastra Business Overview
Table 127. Tragara/Adastra Product
Table 128. Tragara/Adastra Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 129. Tragara/Adastra Recent Development
Table 130. Tocagen Company Details
Table 131. Tocagen Business Overview
Table 132. Tocagen Product
Table 133. Tocagen Revenue in Isocitrate Dehydrogenase Inhibitors Business (2015-2020) (Million US$)
Table 134. Tocagen Recent Development
Table 135. Research Programs/Design for This Report
Table 136. Key Data Information from Secondary Sources
Table 137. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Isocitrate Dehydrogenase Inhibitors Market Share by Type: 2020 VS 2026
Figure 2. IDH1 Mutant Medullary Malignant Tumor Features
Figure 3. IDH2 Mutant Medullary Malignant Tumor Features
Figure 4. Others Features
Figure 5. Global Isocitrate Dehydrogenase Inhibitors Market Share by Application: 2020 VS 2026
Figure 6. DH Inhibitor Case Studies
Figure 7. FLT3 Inhibitor Case Studies
Figure 8. Hedgehog Pathway Inhibitor Case Studies
Figure 9. Others Case Studies
Figure 10. Isocitrate Dehydrogenase Inhibitors Report Years Considered
Figure 11. Global Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth 2015-2026 (US$ Million)
Figure 12. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions: 2020 VS 2026
Figure 13. Global Isocitrate Dehydrogenase Inhibitors Market Share by Regions (2021-2026)
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Isocitrate Dehydrogenase Inhibitors Market Share by Players in 2019
Figure 16. Global Top Isocitrate Dehydrogenase Inhibitors Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Isocitrate Dehydrogenase Inhibitors as of 2019
Figure 17. The Top 10 and 5 Players Market Share by Isocitrate Dehydrogenase Inhibitors Revenue in 2019
Figure 18. North America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Europe Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. China Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Japan Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Southeast Asia Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. India Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Central & South America Isocitrate Dehydrogenase Inhibitors Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. AGIOS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 26. AGIOS Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 27. Aslan Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 28. Aslan Pharmaceuticals Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 29. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 30. Bayer Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 31. Beigene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 32. Beigene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 33. Bristol-Myers Squibb Total Revenue (US$ Million): 2019 Compared with 2018
Figure 34. Bristol-Myers Squibb Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 35. Celgene Total Revenue (US$ Million): 2019 Compared with 2018
Figure 36. Celgene Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 37. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 38. Daiichi Sankyo Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 39. Philogen S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 40. Philogen S.p.A. Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 41. Tesaro Total Revenue (US$ Million): 2019 Compared with 2018
Figure 42. Tesaro Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 43. Tragara/Adastra Total Revenue (US$ Million): 2019 Compared with 2018
Figure 44. Tragara/Adastra Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 45. Tocagen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 46. Tocagen Revenue Growth Rate in Isocitrate Dehydrogenase Inhibitors Business (2015-2020)
Figure 47. Bottom-up and Top-down Approaches for This Report
Figure 48. Data Triangulation
Figure 49. Key Executives Interviewed